Miami, FL, United States of America

Adriana Yndart Arias


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Adriana Yndart Arias

Introduction

Adriana Yndart Arias is a notable inventor based in Miami, FL, who has made significant contributions to the field of medical research. Her work primarily focuses on innovative solutions for treating HIV-associated neurocognitive disorders. With a strong academic background and a commitment to advancing healthcare, she has developed a unique formulation that addresses critical health challenges.

Latest Patents

Adriana holds a patent for her invention titled "Compositions and methods for treating HIV-associated neurocognitive disorders." This invention involves a formulation comprising magnetic nanoparticles (MENPs) conjugated to or mixed with therapeutic cargo, which includes an HIV inhibitor, an inhibitor of BACE-1 activity or expression, and a cocaine antagonist. The formulation can be encapsulated within liposomes that are surface modified with an affinity ligand to target the brain. This innovative approach allows for the treatment of HIV infection in subjects with cocaine addiction by guiding the MENPs across the blood-brain barrier using magnetic forces.

Career Highlights

Adriana is affiliated with Florida International University, where she contributes to research and development in her field. Her dedication to advancing medical science is evident through her innovative patent and ongoing research efforts.

Collaborations

Adriana has collaborated with esteemed colleagues such as Madhavan Nair and Sneham Tiwari, enhancing the impact of her research through teamwork and shared expertise.

Conclusion

Adriana Yndart Arias exemplifies the spirit of innovation in medical research, particularly in the treatment of HIV-associated neurocognitive disorders. Her groundbreaking work and patent reflect her commitment to improving health outcomes for individuals facing these challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…